Thursday, May 30, 2019

Natco settles patent dispute with Onyx Therapeutics for blood cancer drug Carfilzomib

Natco settles patent dispute with Onyx Therapeutics for blood cancer drug Carfilzomib The settlement allows Natco and its partner Breckenridge to launch the generic version of Kyprolos in 2027 or sooner depending on certain occurrences.

from Moneycontrol Business News http://bit.ly/30TCpWv

No comments:

Post a Comment

Bulls return to D-Street as falling oil prices ease geopolitical jitters

Indian stock markets experienced a significant rally on Wednesday. Both the Nifty 50 and S&P BSE Sensex saw gains exceeding 1 percent. T...